FindTrial
Sign In

Role of Clinical Pharmacist in the Management of Acute kidney Injury in Hospitalized patients.

Acute Kidney Injury in Hospitalized patients: Epidemiological trends and the role of clinical pharmacist in its management at a tertiary care teaching Hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/089923
Enrollment
245
Registered
2025-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Sri Adichunchanagiri college of pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than 18 years. Patients diagnosed with AKI based on KDIGO criteria. Patients receiving pharmacological interventions that impact renal function e.g., nephrotoxic drugs. Patients admitted to the hospital for at least 48 hours

Exclusion criteria

Exclusion criteria: Patients with end-stage renal disease (ESRD) or on dialysis. Patients with incomplete medical records or insufficient data for analysis (e.g., Lab reports of RFT and Past medication history). Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Prevalence of Acute kidney injury, Prevalence of drug induced AKITimepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactMohith Shivaramu

Sri Adichunchanagiri college of pharmacy

poojagowda00150@gmail.com8971587200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026